Conformational Analysis and Molecular Modeling of 1-Phenyl-, 4-Phenyl-, and l-Benzyl-l,2,3,4-tetrahydroisoquinolines as D1Dopamine Receptor Ligands

Paul S. Charifson, J. Phillip Bowen, Steven D. Wyrick, Andrew J. Hoffman, Michael Cory, Andrew T. McPhail, Richard Mailman

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Conformational studies on a series of 1-phenyl-, 4-phenyl-, and l-benzyl-l,2,3,4-tetrahydroisoquinolines that possess an identical substituent pattern to the prototypical D1dopamine receptor antagonist SCH23390 [(R)-(+)-7-chloro-8-hydroxy-3-methyl-l-phenyl-2,3,4,5-tetrahydro-lif-3-benzazepine (1)] were performed with use of molecular mechanics calculations {MM2(85), with newly developed aromatic halide bending and torsional parameters that are now incorporated into MM2(87)}, single-crystal X-ray analysis, and high-field NMR spectroscopy. The synthesis and biological testing of compounds 2–7 has been previously reported. The test compounds were compared both quantitatively and graphically to compound 1. Calculations on both the free-base and protonated forms of each compound were carried out. To insure that conformation space was adequately sampled, the test compounds were energy minimized from different starting geometries; ring inversion of the heterocycle was employed, as were dihedral driver calculations on the phenyl or benzyl rings. For N-methyl-6-chloro-7-hydroxy-l-phenyl-l,2,3,4-tetrahydroisoquinoline (2), it was determined that the torsion angle r(C8a-Cl-Cl2-Cl7) had energy minima at approximately 60° and 240°. This finding was corroborated by NMR studies that indicated a dramatic upfield chemical shift of ArH8 after ring cyclization. The nitrogen lone pair or hydrogen vector was approximately orthogonal to the plane of the substituted aromatic ring in the tetrahydroisoquinolines; this explained the upfield chemical shift of the vicinal chiral proton (H1). In all instances, the 6-membered heterocyclic ring in the energy-minimized structures preferred the half-chair conformation with the phenyl rings pseudo-equatorial. Distance comparisons of the proposed pharmacophoric atoms (Cl, N, 0, centroid of the phenyl or benzyl ring) showed that the phenyl or benzyl centroid to ammonium H distance, Cl to N distance, and distance of the nitrogen above or below the plane of the isoquinoline aromatic ring are the distances most highly correlated with biological activity (r = 0.82, 0.75, 0.81, respectively). Resolution and single-crystal X-ray analysis of compound 2 showed the most active enantiomer to possess the S absolute configuration, in contrast to the benzazepine (R)-l. Least-squares fitting of the energy-minimized structures with SYBYL molecular modeling software showed (S)-(+)-2, rather than (R)-(-)-2, gave a better fit to (R)-1. Volume determinations derived from sybyl multifit analyses aided in receptor mapping to qualitatively describe areas of “active” pharmacophore space as well as areas of “inactive” substituent space. A correlation (r = 0.95) was found relating the calculated dipole moment orientations with D1receptor binding affinity.

Original languageEnglish (US)
Pages (from-to)2050-2058
Number of pages9
JournalJournal of Medicinal Chemistry
Volume32
Issue number9
DOIs
StatePublished - Sep 1 1989

Fingerprint

Tetrahydroisoquinolines
Benzazepines
Ligands
Nitrogen
X-Rays
Cyclization
Mechanics
Least-Squares Analysis
Ammonium Compounds
Protons
Hydrogen
Magnetic Resonance Spectroscopy
Software

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Cite this

Charifson, Paul S. ; Bowen, J. Phillip ; Wyrick, Steven D. ; Hoffman, Andrew J. ; Cory, Michael ; McPhail, Andrew T. ; Mailman, Richard. / Conformational Analysis and Molecular Modeling of 1-Phenyl-, 4-Phenyl-, and l-Benzyl-l,2,3,4-tetrahydroisoquinolines as D1Dopamine Receptor Ligands. In: Journal of Medicinal Chemistry. 1989 ; Vol. 32, No. 9. pp. 2050-2058.
@article{05836f92cfa14805845471b8e99e1972,
title = "Conformational Analysis and Molecular Modeling of 1-Phenyl-, 4-Phenyl-, and l-Benzyl-l,2,3,4-tetrahydroisoquinolines as D1Dopamine Receptor Ligands",
abstract = "Conformational studies on a series of 1-phenyl-, 4-phenyl-, and l-benzyl-l,2,3,4-tetrahydroisoquinolines that possess an identical substituent pattern to the prototypical D1dopamine receptor antagonist SCH23390 [(R)-(+)-7-chloro-8-hydroxy-3-methyl-l-phenyl-2,3,4,5-tetrahydro-lif-3-benzazepine (1)] were performed with use of molecular mechanics calculations {MM2(85), with newly developed aromatic halide bending and torsional parameters that are now incorporated into MM2(87)}, single-crystal X-ray analysis, and high-field NMR spectroscopy. The synthesis and biological testing of compounds 2–7 has been previously reported. The test compounds were compared both quantitatively and graphically to compound 1. Calculations on both the free-base and protonated forms of each compound were carried out. To insure that conformation space was adequately sampled, the test compounds were energy minimized from different starting geometries; ring inversion of the heterocycle was employed, as were dihedral driver calculations on the phenyl or benzyl rings. For N-methyl-6-chloro-7-hydroxy-l-phenyl-l,2,3,4-tetrahydroisoquinoline (2), it was determined that the torsion angle r(C8a-Cl-Cl2-Cl7) had energy minima at approximately 60° and 240°. This finding was corroborated by NMR studies that indicated a dramatic upfield chemical shift of ArH8 after ring cyclization. The nitrogen lone pair or hydrogen vector was approximately orthogonal to the plane of the substituted aromatic ring in the tetrahydroisoquinolines; this explained the upfield chemical shift of the vicinal chiral proton (H1). In all instances, the 6-membered heterocyclic ring in the energy-minimized structures preferred the half-chair conformation with the phenyl rings pseudo-equatorial. Distance comparisons of the proposed pharmacophoric atoms (Cl, N, 0, centroid of the phenyl or benzyl ring) showed that the phenyl or benzyl centroid to ammonium H distance, Cl to N distance, and distance of the nitrogen above or below the plane of the isoquinoline aromatic ring are the distances most highly correlated with biological activity (r = 0.82, 0.75, 0.81, respectively). Resolution and single-crystal X-ray analysis of compound 2 showed the most active enantiomer to possess the S absolute configuration, in contrast to the benzazepine (R)-l. Least-squares fitting of the energy-minimized structures with SYBYL molecular modeling software showed (S)-(+)-2, rather than (R)-(-)-2, gave a better fit to (R)-1. Volume determinations derived from sybyl multifit analyses aided in receptor mapping to qualitatively describe areas of “active” pharmacophore space as well as areas of “inactive” substituent space. A correlation (r = 0.95) was found relating the calculated dipole moment orientations with D1receptor binding affinity.",
author = "Charifson, {Paul S.} and Bowen, {J. Phillip} and Wyrick, {Steven D.} and Hoffman, {Andrew J.} and Michael Cory and McPhail, {Andrew T.} and Richard Mailman",
year = "1989",
month = "9",
day = "1",
doi = "10.1021/jm00129a006",
language = "English (US)",
volume = "32",
pages = "2050--2058",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "9",

}

Conformational Analysis and Molecular Modeling of 1-Phenyl-, 4-Phenyl-, and l-Benzyl-l,2,3,4-tetrahydroisoquinolines as D1Dopamine Receptor Ligands. / Charifson, Paul S.; Bowen, J. Phillip; Wyrick, Steven D.; Hoffman, Andrew J.; Cory, Michael; McPhail, Andrew T.; Mailman, Richard.

In: Journal of Medicinal Chemistry, Vol. 32, No. 9, 01.09.1989, p. 2050-2058.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Conformational Analysis and Molecular Modeling of 1-Phenyl-, 4-Phenyl-, and l-Benzyl-l,2,3,4-tetrahydroisoquinolines as D1Dopamine Receptor Ligands

AU - Charifson, Paul S.

AU - Bowen, J. Phillip

AU - Wyrick, Steven D.

AU - Hoffman, Andrew J.

AU - Cory, Michael

AU - McPhail, Andrew T.

AU - Mailman, Richard

PY - 1989/9/1

Y1 - 1989/9/1

N2 - Conformational studies on a series of 1-phenyl-, 4-phenyl-, and l-benzyl-l,2,3,4-tetrahydroisoquinolines that possess an identical substituent pattern to the prototypical D1dopamine receptor antagonist SCH23390 [(R)-(+)-7-chloro-8-hydroxy-3-methyl-l-phenyl-2,3,4,5-tetrahydro-lif-3-benzazepine (1)] were performed with use of molecular mechanics calculations {MM2(85), with newly developed aromatic halide bending and torsional parameters that are now incorporated into MM2(87)}, single-crystal X-ray analysis, and high-field NMR spectroscopy. The synthesis and biological testing of compounds 2–7 has been previously reported. The test compounds were compared both quantitatively and graphically to compound 1. Calculations on both the free-base and protonated forms of each compound were carried out. To insure that conformation space was adequately sampled, the test compounds were energy minimized from different starting geometries; ring inversion of the heterocycle was employed, as were dihedral driver calculations on the phenyl or benzyl rings. For N-methyl-6-chloro-7-hydroxy-l-phenyl-l,2,3,4-tetrahydroisoquinoline (2), it was determined that the torsion angle r(C8a-Cl-Cl2-Cl7) had energy minima at approximately 60° and 240°. This finding was corroborated by NMR studies that indicated a dramatic upfield chemical shift of ArH8 after ring cyclization. The nitrogen lone pair or hydrogen vector was approximately orthogonal to the plane of the substituted aromatic ring in the tetrahydroisoquinolines; this explained the upfield chemical shift of the vicinal chiral proton (H1). In all instances, the 6-membered heterocyclic ring in the energy-minimized structures preferred the half-chair conformation with the phenyl rings pseudo-equatorial. Distance comparisons of the proposed pharmacophoric atoms (Cl, N, 0, centroid of the phenyl or benzyl ring) showed that the phenyl or benzyl centroid to ammonium H distance, Cl to N distance, and distance of the nitrogen above or below the plane of the isoquinoline aromatic ring are the distances most highly correlated with biological activity (r = 0.82, 0.75, 0.81, respectively). Resolution and single-crystal X-ray analysis of compound 2 showed the most active enantiomer to possess the S absolute configuration, in contrast to the benzazepine (R)-l. Least-squares fitting of the energy-minimized structures with SYBYL molecular modeling software showed (S)-(+)-2, rather than (R)-(-)-2, gave a better fit to (R)-1. Volume determinations derived from sybyl multifit analyses aided in receptor mapping to qualitatively describe areas of “active” pharmacophore space as well as areas of “inactive” substituent space. A correlation (r = 0.95) was found relating the calculated dipole moment orientations with D1receptor binding affinity.

AB - Conformational studies on a series of 1-phenyl-, 4-phenyl-, and l-benzyl-l,2,3,4-tetrahydroisoquinolines that possess an identical substituent pattern to the prototypical D1dopamine receptor antagonist SCH23390 [(R)-(+)-7-chloro-8-hydroxy-3-methyl-l-phenyl-2,3,4,5-tetrahydro-lif-3-benzazepine (1)] were performed with use of molecular mechanics calculations {MM2(85), with newly developed aromatic halide bending and torsional parameters that are now incorporated into MM2(87)}, single-crystal X-ray analysis, and high-field NMR spectroscopy. The synthesis and biological testing of compounds 2–7 has been previously reported. The test compounds were compared both quantitatively and graphically to compound 1. Calculations on both the free-base and protonated forms of each compound were carried out. To insure that conformation space was adequately sampled, the test compounds were energy minimized from different starting geometries; ring inversion of the heterocycle was employed, as were dihedral driver calculations on the phenyl or benzyl rings. For N-methyl-6-chloro-7-hydroxy-l-phenyl-l,2,3,4-tetrahydroisoquinoline (2), it was determined that the torsion angle r(C8a-Cl-Cl2-Cl7) had energy minima at approximately 60° and 240°. This finding was corroborated by NMR studies that indicated a dramatic upfield chemical shift of ArH8 after ring cyclization. The nitrogen lone pair or hydrogen vector was approximately orthogonal to the plane of the substituted aromatic ring in the tetrahydroisoquinolines; this explained the upfield chemical shift of the vicinal chiral proton (H1). In all instances, the 6-membered heterocyclic ring in the energy-minimized structures preferred the half-chair conformation with the phenyl rings pseudo-equatorial. Distance comparisons of the proposed pharmacophoric atoms (Cl, N, 0, centroid of the phenyl or benzyl ring) showed that the phenyl or benzyl centroid to ammonium H distance, Cl to N distance, and distance of the nitrogen above or below the plane of the isoquinoline aromatic ring are the distances most highly correlated with biological activity (r = 0.82, 0.75, 0.81, respectively). Resolution and single-crystal X-ray analysis of compound 2 showed the most active enantiomer to possess the S absolute configuration, in contrast to the benzazepine (R)-l. Least-squares fitting of the energy-minimized structures with SYBYL molecular modeling software showed (S)-(+)-2, rather than (R)-(-)-2, gave a better fit to (R)-1. Volume determinations derived from sybyl multifit analyses aided in receptor mapping to qualitatively describe areas of “active” pharmacophore space as well as areas of “inactive” substituent space. A correlation (r = 0.95) was found relating the calculated dipole moment orientations with D1receptor binding affinity.

UR - http://www.scopus.com/inward/record.url?scp=0024425450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024425450&partnerID=8YFLogxK

U2 - 10.1021/jm00129a006

DO - 10.1021/jm00129a006

M3 - Article

C2 - 2527994

AN - SCOPUS:0024425450

VL - 32

SP - 2050

EP - 2058

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 9

ER -